HOME >> BIOLOGY >> NEWS
The amendment to the law on green Genetic Engineering inhibits innovation and research in Germany

This release is also available in German.

The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) sees the draft amendment to the Genetic Engineering Act as a restriction on innovation and research in Germany. If the amendment were to be passed in its current form it runs the risk, in the opinion of the DFG, of putting German researchers at a considerable disadvantage on the international playing field. This is the key theme of the statement on the law on genetic engineering recently released by the DFG.

The DFG primarily opposes three aspects of the draft amendment. For instance, the draft put forward by the German federal government assumes that a particular risk is automatically attached to the introduction of genetically modified organisms (GMOs). In the opinion of the DFG this assumption is not backed up by experimental data.

The inappropriate risk assessment leads to increased red tape and hampers the transfer of the findings of basic research to economically viable processes and products. The draft amendment also intends to hold users of genetically modified organisms responsible for "intrusion" by GMOs into conventionally or ecologically produced seed. However, it is not possible in principle to prevent such cross breeding of genetically modified organisms. If the liability proposed in the amendment is enforced, research involving genetically modified organisms or their release will barely be possible in Germany any longer.

Thirdly, the DFG is against the planned splitting of the Central Commission for Biological Safety into two committees and the inclusion of members who do not have relevant technical expertise. The DFG does not perceive a need for new boards, new bureaucratic regulations or additional authorities.

The envisaged establishment of a federal register for recording the location of GMOs and registers for each of the 16 st
'"/>

Contact: Prof. Dr. Jrg Hacker
j.hacker@mail.uni-wuerzburg.de
49-0-9131-31-2575
Deutsche Forschungsgemeinschaft
6-Jul-2004


Page: 1 2

Related biology news :

1. Plants will not save us from greenhouse gases
2. Environmental decontamination, greenhouse gases, and the genome of a methane-loving bacterium
3. Spring through fall, cities are greener longer than neighboring rural regions
4. Urban heat islands make cities greener
5. Carnegie Mellon University hosts ACS-PRF summer school on green chemistry
6. New space-borne instrument to track greenhouse gases, ozone destroyers, and other pollutants
7. UK small firms pay lip service to green issues
8. Continents played key role in collapse and regeneration of Earths early greenhouse, geologists say
9. White tea beats green tea in fighting germs
10. Improved crop production and fewer greenhouse gases
11. Emerging frontiers genomics grant for blue-green bacteria

Post Your Comments:
(Date:1/22/2015)... 2015  A man-made form of insulin delivered by nasal ... in adults with mild cognitive impairment and Alzheimer,s disease ... at Wake Forest Baptist Medical Center. The ... cognitive impairment (MCI) or mild to moderate Alzheimer,s dementia ...
(Date:1/22/2015)... and POINT ROBERTS, Washington , January 20, ... leading sectors including technology and tech stocks, releases video from ... master pickpocket and security consultant Apollo Robbins . ... talks about the Wocket™ biometric smart wallet, a product of ...
(Date:1/22/2015)... , January 22, 2015 , ... year  The European Patent Office to present a video ... British nominations to be featured: Christofer Toumazou and ... former finalists and winners of the Award   Starting ...
Breaking Biology News(10 mins):Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 2Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 3Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 2Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 3
(Date:1/22/2015)... Dr. Greg Leyer of UAS Labs recently ... Supplements Pre-Conference seminar on probiotics in San Diego, CA. ... education conference for health care professionals. This year’s pre-conference seminar ... probiotics in health. Dr. Leyer spoke about the emerging topics ...
(Date:1/22/2015)... SAN DIEGO , Jan. 22, 2015   ... company, and Sequenom, Inc. (NASDAQ: SQNM ... a development agreement for next generation noninvasive prenatal ... Cypher,s genome interpretation technology, called Mantis™, to advance ...
(Date:12/24/2014)... 24, 2014  United Therapeutics Corporation (NASDAQ: UTHR ... MDT ) has submitted a pre-market approval application to ... use of Medtronic,s SynchroMed ® II implantable drug ... with United Therapeutics, Remodulin ® (treprostinil) Injection delivered ...
(Date:12/24/2014)... Missouri (PRWEB) December 23, 2014 GMO corn ... company, Syngenta, are in the process of being consolidated in ... is In Re: Syngenta AG MIR 162 Corn Litigation, MDL ... of Kansas. , Management of the Syngenta GMO corn multidistrict ...
Breaking Biology Technology:Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order 2
Cached News: